ACCOUNTS - Final Accounts preparation

Company registration number: 08171521

	UNAUDITED FINANCIAL STATEMENTS
	FOR THE YEAR ENDED 31 DECEMBER 2024

	TOUCH A NERVE LIMITED


TOUCH A NERVE LIMITED

COMPANY INFORMATION

Directors	G N P Harrison
	J Pryor
	C Matthews


Registered number	08171521


Registered office	Htf Business Centre
	Heath End Road
	Flackwell Heath
	Buckinghamshire
	HP10 9QH


Accountants	Menzies LLP
	Chartered Accountants
	Magna House
	18-32 London Road
	Staines-Upon-Thames
	TW18 4BP


TOUCH A NERVE LIMITED

CONTENTS

	Page
Statement of financial position	1 - 2
Notes to the financial statements	3 - 4


TOUCH A NERVE LIMITED REGISTERED NUMBER:08171521

STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2024

		2024		2023
Note		£		£

Fixed assets
Investments	4		320,000		320,000
			320,000		320,000
Current assets
Cash at bank and in hand		980		980
		980		980
Creditors: amounts falling due within one year	5	(285,840)		(285,840)
Net current liabilities			(284,860)		(284,860)
Total assets less current liabilities			35,140		35,140

Net assets			35,140		35,140

Capital and reserves
Called up share capital	1,000	1,000
Share premium account	9,980	9,980
Profit and loss account	24,160	24,160
	35,140	35,140

Page 1


TOUCH A NERVE LIMITED REGISTERED NUMBER:08171521

STATEMENT OF FINANCIAL POSITION (CONTINUED)

AS AT 31 DECEMBER 2024

For the year ended 31 December 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

J Pryor

Director

Date: 5 September 2025

The notes on pages 3 to 4 form part of these financial statements.

Page 2


TOUCH A NERVE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

1.	General information

Touch A Nerve Limited is a private company, limited by shares, incorporated in England and Wales. The registered number, registered office address and principal place of business is noted in the Company information page.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

2.2

Exemption from preparing consolidated financial statements

The company, and the group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent and group are considered eligible for the exemption to prepare consolidated accounts.

2.3

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

2.4

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Employees

The average monthly number of employees, including directors, during the year was 3 (2023 - 2).

4.	Fixed asset investments

		Investments in subsidiary companies
		£
	Cost or valuation
	At 1 January 2024	320,000
	At 31 December 2024	320,000

Page 3


TOUCH A NERVE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

5.	Creditors: Amounts falling due within one year
		2024	2023
		£	£

Amounts owed to group undertakings	285,840	285,840
	285,840	285,840

Page 4